Artificial Insemination Market - By Type: Sperm Donation, Oocyte Donation. By Application: Livestock Breeding, Human Fertility. By End-user: Hospitals, Fertility Clinics, Veterinary Clinics. By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
The Global Artificial Insemination Market was valued at USD 2.1 billion in 2023 and is projected to reach USD 4.3 billion by 2031, growing at a CAGR of 9.2%. The market is expanding due to rising infertility rates, advancements in assisted reproductive technology (ART), and an increasing acceptance of AI procedures in both humans and livestock.
2024 Market Breakthroughs
Market Drivers
Competitive Landscape
|
Company |
Market Share |
Flagship Innovation |
Strategic Edge |
|
CooperSurgical |
28% |
Gavi® Sperm Prep |
Leading human fertility segment |
|
STgenetics |
22% |
SexedULTRA™ gender-sorted semen |
Livestock AI dominance |
|
Vitrolife |
XX% |
AI Sperm Selection System |
High IVF clinic adoption |
Emerging Disruptors:
Market Segmentation
Recent Developments (2024)
Need help?
Chat with our team in a minute.